Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Use of Empagliflozin in Patients with Heart Failure with Preserved Ejection Fraction in a Cardiology Outpatient Department

NCT06683053 is registered in ClinicalTrials.gov with Conrado Roberto Hoffmann Filho as lead sponsor.

NCT NCT06683053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06683053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Use of Empagliflozin in Patients with Heart Failure with Preserved Ejection Fraction in a Cardiology Outpatient Department
Lead sponsor
Conrado Roberto Hoffmann Filho
Phase
Phase 3
Overall status
Active, not recruiting
Start date
March 17, 2023
Completion date
February 28, 2025
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congestive heart failure (chf)